State of Wisconsin Investment Board
OVID icon

State of Wisconsin Investment Board’s Ovid Therapeutics OVID Stock Holding History

State of Wisconsin Investment Board’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-69,100
Closed -$397K – 2006
2020
Q3 		$397K Buy
+69,100
New +$462K ﹤0.01% 1559
2019
Q2 		– Sell
-17,600
Closed -$31K – 1584
2019
Q1 		$31K Buy
17,600
+4,000
+29% +$10K ﹤0.01% 1534
2018
Q4 		$33K Buy
+13,600
New +$62.1K ﹤0.01% 1535

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wisconsin Investment Board's OVID Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Ovid Therapeutics (OVID) in Q4 2020, closing a stake of 69,100 shares — an estimated $397K sold.

State of Wisconsin Investment Board first reported a position in OVID in Q4 2018 and held it in 3 quarters. The position peaked at $397K in Q3 2020. 83 funds tracked by Wall St. Rank hold OVID as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Ovid Therapeutics position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 69,100 Ovid Therapeutics shares in Q4 2020, an estimated $397K.
  • State of Wisconsin Investment Board first reported a position in Ovid Therapeutics in Q4 2018 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Ovid Therapeutics position peaked at $397K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.